ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹106 Cr | ₹97 Cr | ₹87 Cr | ₹121 Cr | ₹115 Cr |
What is the latest Contingent Liabilities ratio of ABBOTT INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹87 Cr |
| Mar2022 | ₹121 Cr |
| Mar2021 | ₹115 Cr |
How is Contingent Liabilities of ABBOTT INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹106 Cr | 10.00 | |
| Mar2024 | ₹97 Cr | 10.44 | |
| Mar2023 | ₹87 Cr | -28.00 | |
| Mar2022 | ₹121 Cr | 5.32 | |
| Mar2021 | ₹115 Cr | - | |
Compare Contingent Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,738.6 Cr | -2% | -3.8% | 3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -2% |
-3.8% |
3% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses